Novo Nordisk and UNICEF renew push to prevent childhood obesity
Novo Nordisk and UNICEF renew push to prevent childhood obesity Sept 22 (Reuters) - Novo Nordisk NOVOb.CO and UNICEF have expanded their partnership to help prevent childhood overweight and obesity, the Danish drugmaker said on Tuesday.
The expansion follows UNICEF's 2025 Child Nutrition Report that found childhood obesity had overtaken underweight for the first time on record.
Novo will commit an additional $18 million from 2026 through 2030 to support prevention initiatives in Mexico, Colombia, Indonesia, the Philippines, India, Egypt and Kenya, Senior Vice President Elin Jäger told Reuters.
This will include interventions such as nutrition and physical activity counselling or basic mental health screening and support, Novo said.
The four-year programme will run from 2027 to 2030, with funding starting in 2026, and aims to reach more than 80 million children.
The expansion is part of Novo's updated sustainability strategy launching next week, Jäger said.
(Reporting by Patrick Wingrove, writing by Vera Dvorakova; Editing by Milla Nissi-Prussak)
((vera.dvorakova@thomsonreuters.com))
Recent news on Novo Nordisk A/S
See all newsFocus: Beauty giants target 'Ozempic face' as boom in obesity drugs opens new market
Factbox: Anthropic's public benefit fund and how it compares with other big philanthropic efforts
Novo's CagriSema helped women lose 25% of weight on average, analysis shows
As weight-loss drug users turn to dietary supplements, doctors, regulators raise flags
Factbox: Major drugmakers turn to China for licensing deals